Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof

Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof

US Patent 11739101 · Granted Aug 29, 2023

Estimated economic value: $5,819,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for CD73 modulation and indications therefor2025
3-substituted piperidine compounds for Cbl-b inhibition, and use thereof2025
Plasma kallikrein inhibitors2025
Amorphous and crystalline forms of IDO inhibitors2025
Modulators of BCL6 as ligand directed degraders2025
Antiviral pyrazolopiridinone compounds2025
Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piper2025
Substituted 6-azabenzimidazole compounds2025
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses the2025
Compounds and methods for CD73 modulation and indications therefor2025
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses t2024
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses t2024